Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 9 Billion | USD 38 Billion | 10% | 2023 |
The global aesthetics injectables market size was evaluated at $9 billion in 2023 and is slated to hit $38 billion by the end of 2032 with a CAGR of nearly 10% between 2024 and 2032.
Aesthetic injectables are non-surgical treatments devised to improve facial features, minimize aging signs, and enhance skin appearance. Moreover, there are two kinds of aesthetic injectables, namely, dermal fillers and neurotoxins. Furthermore, each of these products serves a distinct purpose and uses active ingredients for achieving the required aesthetic outcomes.
Key Insights
Huge popularity of non-surgical cosmetic surgeries will propel the global market expansion by 2032
Escalating demand for non-surgical cosmetic methods and technological breakthroughs can prop up the expansion of the global aesthetics injectables market. Moreover, changing customer trends along with a surge in the per capita income and cost-efficiency of the product will craft a profitable roadmap for the global market. In addition, supportive government laws and demographic shifts can enlarge the scope of the global market.
Apart from this, the launch of new products, such as bio-stimulators, will spur market expansion over the coming eight years. Flourishing medical tourism sector and the use of minimally invasive methods for acne scar treatment and wrinkle reduction will drive the global market expansion.
Stringent legislation regulating product usage can restrict the global industry surge over 2024-2032
Strict laws governing the use of the product and licensing issues can severely impact the expansion of the global aesthetics injectables industry. Additionally, side effects such as redness, swelling, and bruises associated with product usage can obstruct the global industry surge. Easy availability of substitute products can retard the global industry surge in the ensuing years.
A surge in the disposable income in the emerging economies will open new growth avenues for the global market
An increase in the per capita income in developing countries and the presence of key players in these countries are expected to generate new growth avenues for the global aesthetics injectables market. Furthermore, firms across the globe are increasing their product lines, thereby proliferating the expansion of the global market.
An increasing product prices can create obstacles in the elevation of industry growth in the coming years
High costs of the product along with a rise in costs of treatment can obstruct the expansion of the global aesthetic injectables industry. Moreover, economic downturns along with rising inflation can affect the industry elevation in the ensuing years.
The global aesthetics injectables market is divided into product type, application, end-user, and region.
In terms of product type, the aesthetics injectables market across the globe is segmented into neurotoxins, platelet-rich plasma, and dermal fillers segments. Apparently, the dermal fillers segment, which amassed nearly 71% of the global market revenue in 2023, is anticipated to record the fastest CAGR in the next few years subject to their versatility and ability to facial contour as well as volume restoration.
Based on the application, the global aesthetics injectables industry is segmented into wrinkle reduction, hand rejuvenation, lip enhancement, facial contouring, and non-surgical facelift segments. Apparently, the wrinkle reduction segment, which dominated the global industry in 2023, is expected to contribute notably towards the segmental surge in the ensuing years. This can be owing to a surge in the occurrence of age-related wrinkles and fine lines in the geriatric population.
On the basis of end-user, the global aesthetics injectables market is sectored into dermatologists, hospitals & clinics, beauty salons, plastic surgeons, and medical spas segments. Moreover, the dermatologists segment, which led the end-user segment in 2023, is projected to lead the segmental space in the forecast timeframe.
Additionally, the segmental surge can be credited to the massive use of the product by dermatologists for treating skin patches as well as skin-related ailments. These products are preferred by dermatologists for performing aesthetic surgeries on patients.
Report Attributes | Report Details |
---|---|
Report Name | Aesthetics Injectables Market |
Market Size in 2023 | USD 9 Billion |
Market Forecast in 2032 | USD 38 Billion |
Growth Rate | CAGR of 10% |
Number of Pages | 222 |
Key Companies Covered | Anika Therapeutics Inc., Huadong Medicine Co. Ltd., AbbVie Inc., Galderma S.A., Merz Pharma GmbH & Co KgaA, Revance Therapeutics Inc., Ipsen Pharma, Medytox, Suneva Medical, Teoxane SA., and others. |
Segments Covered | By Product Type, By Application, By End-User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is likely to maintain leading status in the global market over the projected time-interval
North America, which contributed about 54% of the global aesthetics injectables market size in 2023, is likely to establish a leading position in the global market in the ensuing years. Apart from this, the regional market progression in the next few years can be credited to surging per capita income of end-users along with acceptance of novel technologies and introduction of strong laws.
Furthermore, huge awareness about product benefits leading to their high rate of acceptance is projected to foster the regional market trends.
Asia-Pacific aesthetics injectables industry is likely to record the fastest compounded growth annually in the ensuing years. The elevation of the industry in the APAC zone can be a result of a rise in the middle-income group population opting for aesthetic injectable treatment in Asian countries. Apart from this, a rise in healthcare spending and the popularity of aesthetic treatment for maintaining a youthful appearance will push the growth of the industry in the region.
The global aesthetics injectables market profiles key players such as :
By Product Type
By Application
By End-User
FrequentlyAsked Questions
Aesthetic injectables are non-surgical treatments devised to improve facial features, minimize aging signs, and enhance skin appearance.
The global aesthetics injectables market's growth over the forecast period can be attributed to Escalating demand for non-surgical cosmetic methods and technological breakthroughs.
According to a study, the global aesthetics injectables industry size was $9 billion in 2023 and is projected to reach $38 billion by the end of 2032.
The global aesthetics injectables market is anticipated to record a CAGR of nearly 10% from 2024 to 2032.
The Asia-Pacific aesthetics injectables industry is set to register the fastest CAGR over the forecasting timeframe owing to swift industrialization, favorable government policies, and rapid economic development. The surging use of these products in the food and pharmaceuticals sectors is anticipated to prop up the regional industry trends.
The global aesthetics injectables market is led by players such as Anika Therapeutics, Inc., Huadong Medicine Co., Ltd., AbbVie Inc., Galderma S.A., Merz Pharma GmbH & Co KgaA, Revance Therapeutics, Inc., Ipsen Pharma, Medytox, Suneva Medical, and Teoxane SA.
The global aesthetics injectables market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, cash-benefit analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, factor analysis, and value chain analysis. It provides an apt scenario about demand and factor conditions in the country impacting the profitability of the firms in the domestic and international markets.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed